With the growing demand for biologics and ready-to-administer syringes, recent reports have predicted the global pre-filled syringes (PFS) market to reach $6.6bn by 2020. While the PFS industry has witnessed booming investment, it still needs to overcome a number of hurdles.Through a combination of powerful keynote addresses, topical debate and interactive workshops, Pre-Filled Syringes East Coast will once again play host to an audience of senior scientists, device manufacturers and PFS professionals, providing a focal point to discuss the latest innovations; as well as honing in on industry challenges and regulatory compliance.Speakers include:• Stephen Barat, Executive Dir, Non-Clinical & Translational Sciences, Safety Assessment & Bioanalysis, Allergan• Mathias Romacker, Senior Dir, Device Strategy, Pfizer• Dr. Paolo Mangiagalli, Senior Dir, Head PFS Platform, Sanofi• Ken Wong, Deputy Director, MTech/ Process Technology – Extractables & Leachables, Sanofi Pasteur• Carsten Worsoe, Principal Scientist, CMC Analytical Support, Novo Nordisk A/S• Dr. Shawn Davis, Principal Engineer, Device Strategy, Amgen• Mohammed Umar, Principal Technical Manager, Quality Engineering, Genentech• Jason Lipman, Associate Dir, Regulatory Affairs, Medical Devices & Combination Products, Janssen R&D, LLCReasons to attend:• Discover how to eliminate extractables & leachables (E&L) • Incorporate human factor engineering into a patient-centric device• Ensure commercial competitiveness of PFS as a drug device• Assess trends of combination products and impacts on PFS• Learn about the latest cutting edge technological developments in COP and sterilization• Exclusive workshops led by Cambridge Consultants and FDAPharma Cosulting LLCFor further details and to download a brochure, visit the website.